Susanne Hartmann

Summary

Affiliation: Merz Pharmaceuticals
Country: Germany

Publications

  1. ncbi request reprint Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy
    Susanne Hartmann
    Medical Affairs, Merz Pharmaceuticals GmbH, Frankfurt Main, Germany
    Int Clin Psychopharmacol 18:81-5. 2003

Detail Information

Publications1

  1. ncbi request reprint Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy
    Susanne Hartmann
    Medical Affairs, Merz Pharmaceuticals GmbH, Frankfurt Main, Germany
    Int Clin Psychopharmacol 18:81-5. 2003
    ..Global clinical status of most patients was judged as improved (54%) or stable (39%) over the observation period. These findings particularly suggest that memantine in combination with AChEIs is safe and well tolerated...